Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
- 1 October 2005
- journal article
- Published by Elsevier in Biomaterials
- Vol. 26 (29) , 5898-5906
- https://doi.org/10.1016/j.biomaterials.2005.02.038
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytesBiomaterials, 2004
- DNA Nanoparticles and Development of DNA Delivery Vehicles for Gene TherapyBiochemistry, 2002
- Nanoparticulate systems for brain delivery of drugsPublished by Elsevier ,2001
- Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groupsInternational Journal of Pharmaceutics, 2000
- Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acidEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeuticsJournal of Controlled Release, 2000
- A Novel Biodegradable System Based on Gelatin Nanoparticles and Poly(lactic-co-glycolic acid) Microspheres for Protein and Peptide Drug DeliveryJournal of Pharmaceutical Sciences, 1997
- Infection of monocytes/macrophages by HIV in vitroResearch in Virology, 1990
- Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein ANature, 1980